Onglyza™ & Kombiglyze® XR may be linked to Heart Failure
If you used the type 2 diabetes drug Onglyza™ or Kombiglyze® XR and were hospitalized or required medical treatment for heart failure, you may be entitled to a cash award. Call the Gold Shield Group toll free 888-723-5291 for a free/no obligation case review.
What is the problem?
A study published in the New England Journal of Medicine revealed that people using Onglyza™ and Kombiglyze® XR are at an increased risk of heart failure, a condition where the heart is weakened and does not pump enough blood to met the body's needs. As a result, the Food and Drug Administration launched an investigation that resulted in recommending that Onglyza™ and Kombiglyze® XR should carry information about the risk of heart failure on their labels.
Side effects of Onglyza™ and Kombiglyze® XR:
The active ingredient in Onglyza™ and Kombiglyze® XR is Saxagliptin, a type of medication known as a DPP-4 inhibitor. It works by increasing the body’s supply of incretin, a hormone that helps regulate the release of insulin. Saxagliptin has been associated with an increased risk of heart failure. Specific heart issues include:
• Heart Failure
• Cardiac Failure
• Congestive Heart Failure
If you used the type II diabetes drugs Onglyza™ or Kombiglyze® XR and suffered heart failure, congestive heart failure, or cardiac failure, or if a loved one died as a result of any of these complications after using Onglyza™ or Kombiglyze® XR, you may be entitled to a CASH AWARD. Call the Gold Shield Group toll free at 888-723-5291.